[1]
|
S. Lai, Y. Susan, J. Mandel and R. S. Weber, “Disorders of the Thyroid Gland,” In: C. W. Cummings, B. H. Haughey, J. R. Thomas, L. A. Harker, K. Robins, P. W. Flint, D. Schuller and R. M. Cummings, Eds., Otolaryngology: Head and Neck Surgery, Mosby Pub, Inc., 2005.
|
[2]
|
S. Margo, A. Stojadinovic, A. Nissan, R. A. Ghossein, S. Freedman, M. F. Brennan, J. P. Shah and A. R. Shaha, “Prognostic Indicators of Outcomes in Patients with Distant Metastases from Differentiated Thyroid Carcinoma,” Journal of the American College of Surgeons, Vol. 197, No. 2, 2003, pp. 191-197.
doi:10.1016/S1072-7515(03)00332-6
|
[3]
|
C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J. P. Travagli, B. Caillou, M. Ricard, J. D. Lumbroso, F. De Vathaire and M. Schlumberger, “Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy,” Journal of Clinical Endocrinology & Metabolism, Vol. 91, No. 8, 2006, pp. 2892-2899.
doi:10.1210/jc.2005-2838
|
[4]
|
C. A. Benbassat, S. Mechlis-Frish and D. Hirsch, “Clinicopathological Characteristics and Long-Term Outcome in Patients with Distant Metastases from Differentiated Thyroid Cancer,” World Journal of Surgery, Vol. 30, No. 6, 2006, pp. 1088-1095. doi:10.1007/s00268-005-0472-4
|
[5]
|
M. Haq and C. Harmer, “Differentiated Thyroid Carcinoma with Distant Metastases at Presentation: Prognostic Factors and Outcome,” Clinical Endocrinology, Vol. 63, No. 1, 2005, pp. 87-93.
doi:10.1111/j.1365-2265.2005.02304.x
|
[6]
|
National Comprehensive Cancer Network, “NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma,” 2011.
http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
|
[7]
|
American Thyroid Association, “Thyroid Clinical Trials,” Falls Church, 2011. http: //thyroidtrials.org/
|